Eric Lazer - 14 Sep 2021 Form 3/A - Amendment Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Not a 10% owner
Signature: /s/ Eric Lazer
Issuer symbol: KTTA
Transactions as of: 14 Sep 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 07 Oct 2021, 16:07:00 UTC
Date Of Original Report: 14 Sep 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KTTA	Common Stock						902,600	14 Sep 2021	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This Form 3 was originally and incorrectly filed to disclose Eric Lazer as a 10% holder, specifically owning 902,600 shares of Common Stock through Roxy Capital Corporation ("Roxy"). Mr. Lazer is the Director of Roxy and has sole voting and investment control with respect to the shares held by Roxy. As such, Mr. Lazer may be deemed to beneficially own the shares held directly by Roxy. At this time, the 902,600 shares of Common Stock held by Roxy represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Lazer is not a 10% holder.

Content

This Form 3 was originally and incorrectly filed to disclose Eric Lazer as a 10% holder, specifically owning 902,600 shares of Common Stock through Roxy Capital Corporation ("Roxy"). Mr. Lazer is the Director of Roxy and has sole voting and investment control with respect to the shares held by Roxy. As such, Mr. Lazer may be deemed to beneficially own the shares held directly by Roxy. At this time, the 902,600 shares of Common Stock held by Roxy represent less than 10% of the Common Stock. This amended Form 3/A discloses that Mr. Lazer is not a 10% holder.